Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on PROTEOME SCIENCES PLC. We currently have 16 research reports from 2 professional analysts.
|04Jan17 04:39||RNS||Holdings in Company / PDMR Shareholding|
|03Jan17 01:37||RNS||Holdings in Company / PDMR Shareholding|
|30Dec16 11:42||RNS||Holding(s) in Company|
|19Dec16 07:00||RNS||Launch of new website|
|16Dec16 09:28||RNS||Holding(s) in Company|
|29Nov16 10:43||RNS||Result of GM and Completion of Placing|
|18Nov16 09:46||RNS||Holding(s) in Company|
Frequency of research reports
Research reports on
PROTEOME SCIENCES PLC
PROTEOME SCIENCES PLC
29 Nov 16
The prospect of Hilary Clinton creating an oversight panel with the power to impose a set of harsh enforcement rules to control aggressive pricing of pharmaceuticals in the US fell away with the election of Trump, leading to a 16% bounce in the NASDAQ Biotech index and an 8% increase in the US Pharma & Biotech index, some of which has already been given back.
31 Oct 16
Hutchison China Medi (HCM.L) | Petards Group* (PEG.L) | Milestone Group (MSG.L) | Limitless Earth (LME.L) | Range Resources (RRL.L) | European Metals Holdings (EMH.L) | Stellar Diamonds (STEL.L) | Plant Impact (PIM.L) | Proteome Sciences (PRM.L) | Premier African Minerals (PREM.L)
£3.3m Placing – cash flow positive in 2018
31 Oct 16
The company announced a Placing and Subscription to raise £3.3m of gross funds, with the explicit intention of driving the business beyond cash flow breakeven in two years. After appointing Jeremy Haigh, an experienced biopharmaceutical industry leader, as CEO in June, a complete review of the business was undertaken resulting in the adoption of a more focused and goal-oriented business strategy. This involves selling a premium contract service-based biomarker business, underpinned with a bioinformatics capability, whilst ensuring that it has the capacity to meet Thermo Fisher Scientific’s exploitation of PRM’s proprietary TMT reagents.
22 Sep 16
Cambridge Cognition Hldgs* (COG.L) | Venn life Sciences* (VENN.L) | Conroy Gold & Natural Resources (CGNR.L) | First Property Group (FPO.L) | Secure Property Development & Investment (SPDI.L) | LXB Retail Properties (LXB.L) | Union Jack Oil (UJO.L) | Elektron Technology (EKT.L) | Proteome Sciences (PRM.L) | DJI Holdings (DJI.L)
N+1 Singer - Small-cap quantitative research - Momentum screen refresh + 10 focus stocks
12 Jan 17
We have refreshed our momentum style screen for the first time since inception on 26 July 2016. As before, the screen selects the 25 stocks exhibiting the most extreme momentum characteristics, according to our measurement method. From these we have selected 10 to focus on. Since inception the screen has underperformed both the main small-cap and micro-cap indices against a background of generally rising momentum. We have noted a subset of the basket, where decelerating momentum at the time of measurement appears correlated with significant share price falls since selection. We shall monitor this factor with the new screen, albeit there are only two such stocks showing this pattern, namely Lamprell (not rated) and Gear4music (not rated).
N+1 Singer - Morning Song 12-01-2017
12 Jan 17
As anticipated, the second half has again been stronger than H1 and results will be broadly in line with expectations. In line with this, the order book has continued to grow and is at record levels. This confirms that significant progress has been made in the Group’s shift towards its Technology Products division which, as targeted, contributed c.60% of group revenue in FY16. The small acquisition of Cable Power also gives a complementary boost to the product range. It is also worth noting the significant reduction in net debt, £1.0m ahead of our forecast. We remain supportive of the Group’s strategy and continue to see a bright future as this transition towards a design led technology solutions business continues. We look forward to more detail in March at the final results.
N+1 Singer - Best Ideas 2017 - Top picks
04 Jan 17
Today we publish our Best Ideas for 2017 - 12 stocks that we believe have excellent prospects in the current year together with a detailed discussion of what we see as the key sector and market themes for 2017. Our top picks are Cineworld, Elementis, Herald Investment Trust, Hill & Smith, IQE, MySale, Redde, ReNeuron, RhythmOne, SDL, Servelec and Severfield.
The Monthly January 2017
09 Jan 17
Despite all the hullaballoo of the Brexit vote and the subsequent election of Donald Trump as the next US President, the UK stock market prospered last year, especially in the latter few months of 2016. The combination of a depreciating currency – making $ earnings more valuable in relative terms - and the Trump emphasis on infrastructure expenditure drove the stock market higher
10 for 17
09 Jan 17
As always at the start of a year, there are significant uncertainties about the year ahead but I think in 2017, the level of uncertainly has decisively moved up a gear. In fact, a leading economist at the LSE, Ethan Ilzetzki, was recently quoted as saying “I view the current global economic environment as the most uncertain in modern history”. Wow.